in morbidity and mortality. The time to act is now – before we lose these
‘miracle’ drugs for good.”- “The scourge of antimicrobial resistance has increased inexorably over the years.
We believe that the window for overcoming antimicrobial resistance is still open,
but we must act decisively now – Australia cannot bury its head in the sand any
longer and hope that the problem will just go away.”
Grady, Denise. (January 7th, 2015). New antibiotic stirs hope against resistant bacteria.
The New York Times. http://www.nytimes.com/2015/01/08/health/from-a-pile-of-dirt-
hope-for-a-powerful-new-antibiotic.html?_r=0
- “An unusual method for producing antibiotics may help solve an urgent global
problem: the rise in infections that resist treatment with commonly used drugs,
and the lack of new antibiotics to replace ones that no longer work. The method,
which extracts drugs from bacteria that live in dirt, has yielded a powerful new
antibiotic, researchers reported in the journal Nature on Wednesday.”
Gu, B., Kelesidis, T., Tsiodras, et al. (2012). The emerging problem of linezolid-
resistant Staphylococcus. Journal of Antimicrobial Chemotherapy. 68(1). pg. 4-11.
http://jac.oxfordjournals.org/cgi/pmidlookup?view=long&pmid= 22949625
Hammerum, A., Heuer, O., Emborg, H., et al. (2007). Danish integrated antimicrobial
resistance monitoring and research program. Emerging Infectious Disease. 13. pg.
1632 -9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375779/
Hammerum, A., Lester, C. and Heuer, O. (2010). Antimicrobial-resistant enterococci in
animals and meat: A human health hazard? Foodborne Pathogens and Disease. 7. pg.
1137 -46. http://www.ncbi.nlm.nih.gov/pubmed/20578915
Han, F., Lestari, S., Pu, S. and Ge, B. (2009). Prevalence and antimicrobial resistance
among Campylobacter spp. in Louisiana retail chickens after the enrofloxacin ban.
Foodborne Pathogens and Disease. 6. pg. 163-71.
http://www.ncbi.nlm.nih.gov/pubmed/19099357
Harbath, S. and Samore, M. (2005). Antimicrobial resistance determinants and future
control. Emerging Infectious Diseases. 11(6). pg. 794-801.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367590/
- “At the beginning of the 21st century, antimicrobial resistance is common, has
developed against every class of antimicrobial drug, and appears to be spreading
into new clinical niches. We describe determinants likely to influence the future
epidemiology and health impact of antimicrobial-resistant infections.